Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|September 23, 2022
Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse PopulationsJoseph Mikhael, Manisha Bhutani, Craig E Cole
Cureus|May 15, 2023
A Typical Presentation of an Atypical Condition: Hepatic Angiosarcoma With Peritoneal BleedSoha Afzal, Chintan Patel, Santosh Kagathur, et al.
Blood Cancer Journal|August 27, 2024
Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panelRahul Banerjee, Yelak Biru, Craig E Cole, et al.
Cancers|November 14, 2023
Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and SurvivalJonathan D Diedrich, Craig E Cole, Matthew J Pianko, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2023
Creating Equitable and Inclusive Clinical Trials for Multiple MyelomaMonique Hartley-Brown, Craig E Cole, Pamela Price, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Symptom Burden, Perceived Control, and Quality of Life Among Patients Living With Multiple MyelomaAlexandra K Zaleta, Melissa F Miller, Julie S Olson, et al.
Annals of Hematology|January 15, 2008
Circulating endothelial cells in patients with chronic lymphocytic leukemiaRonald S Go, Dean A Jobe, Krista E Asp, et al.
The Journal of Biological Chemistry|December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cellsKlaus Podar, Yu-Tzu Tai, Craig E Cole, et al.
Patient Preference and Adherence|March 8, 2022
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United StatesDaniel Auclair, Carol Mansfield, Mark A Fiala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphomaPeter H Wiernik, Izidore S Lossos, Joseph M Tuscano, et al.
Pageof 2